Tapping into a cancer patient's "yin and yang" immunity could help boost their chances of survival, according to two new ...

Researchers at the Spanish National Cancer Research Center (CNIO) propose a new treatment for brain metastases that respond ...

A new treatment has been proposed for immunotherapy-resistant brain metastases, with a biomarker identified that can predict ...

An immunotherapy drug that could save some cancer patients from the ordeal of extreme chemotherapy may also help them live longer, researchers say. In a trial, pembrolizumab kept head and neck ...

A Cleveland Clinic-led research collaboration between Timothy Chan, MD, PhD, Chair of Cleveland Clinic’s Global Center for ...

Nouscom has also exclusively out-licensed VAC-85135, an off-the-shelf immunotherapy developed under a multi-project agreement, which is currently under evaluation in a Phase 1 trial for the treatment ...

North America Cancer Immunotherapy Market is expanding rapidly due to expanding approval of immunotherapeutic drugs for the treatment of increasing incidences of cancer and increasing investments in ...

The global allergy immunotherapy market is projected to reach USD 1.74 billion in 2023, with robust growth expected over the ...

Immunotherapy biologics represent a transformative approach in treating cancer and infections by using biological molecules to strengthen the immune system’s response. Biologics such as monoclonal ...

Cancer cells are adept at evading detection. They use various strategies to hide from the immune system and even repel attacks. Immunotherapy aids the immune system in recognising, attacking, and ...

Or from your operation if you had one. The results of the tests show whether a targeted cancer drug or immunotherapy is suitable for you. If your cancer has a particular protein on its surface, your ...